Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio
$22.05Billion– No. of Holdings #160
FARALLON CAPITAL MANAGEMENT LLC Performance:
2024 Q1: 8.18%YTD: 8.18%2023: 30.28%
Performance for 2024 Q1 is 8.18%, and YTD is 8.18%, and 2023 is 30.28%.
About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings
FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in SAN FRANCISCO, CA. On 20-Jul-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $41.2 Billions. In it's latest 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $22.1 Billions as of 31 Mar, 2024.
The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are PXD, UNH, IQV. The fund has invested 4.2% of it's portfolio in PIONEER NAT RES CO and 3.8% of portfolio in UNITEDHEALTH GROUP INC.
The fund managers got completely rid off CHARTER COMMUNICATIONS INC N (CHTR), BLACKSTONE INC (BX) and SPLUNK INC (SPLK) stocks. They significantly reduced their stock positions in CRINETICS PHARMACEUTICALS IN (CRNX), IOVANCE BIOTHERAPEUTICS INC (IOVA) and HCA HEALTHCARE INC (HCA). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in AIRBNB INC (ABNB), AON PLC (AON) and GRAYSCALE BITCOIN TR BTC. The fund showed a lot of confidence in some stocks as they added substantially to VAXCYTE INC (PCVX), NEW ORIENTAL ED & TECHNOLOGY (EDU) and HIMS & HERS HEALTH INC (HIMS).
The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are PXD, UNH, IQV. The fund has invested 4.2% of it's portfolio in PIONEER NAT RES CO and 3.8% of portfolio in UNITEDHEALTH GROUP INC.
The fund managers got completely rid off CHARTER COMMUNICATIONS INC N (CHTR), BLACKSTONE INC (BX) and SPLUNK INC (SPLK) stocks. They significantly reduced their stock positions in CRINETICS PHARMACEUTICALS IN (CRNX), IOVANCE BIOTHERAPEUTICS INC (IOVA) and HCA HEALTHCARE INC (HCA). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in AIRBNB INC (ABNB), AON PLC (AON) and GRAYSCALE BITCOIN TR BTC. The fund showed a lot of confidence in some stocks as they added substantially to VAXCYTE INC (PCVX), NEW ORIENTAL ED & TECHNOLOGY (EDU) and HIMS & HERS HEALTH INC (HIMS).
FARALLON CAPITAL MANAGEMENT LLC Equity Portfolio Value
Last Reported on: 24 May, 2024
FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500
Our best estimate is that FARALLON CAPITAL MANAGEMENT LLC made a return of 8.18% in the last quarter. In trailing 12 months, it's portfolio return was 34.67%.
New Buys
| Ticker | $ Bought |
|---|---|
| airbnb inc | 265,292,000 |
| aon plc | 210,911,000 |
| grayscale bitcoin tr btc | 85,221,200 |
| icon plc | 60,370,200 |
| liquidia corporation | 30,311,200 |
| geron corp | 24,733,500 |
| progyny inc | 22,607,700 |
| apogee therapeutics inc | 20,267,200 |
New stocks bought by FARALLON CAPITAL MANAGEMENT LLC
Additions
| Ticker | % Inc. |
|---|---|
| vaxcyte inc | 11,000 |
| new oriental ed & technology | 4,630 |
| hims & hers health inc | 3,890 |
| bruker corp | 2,670 |
| cogent biosciences inc | 2,617 |
| altimmune inc | 1,282 |
| lantheus hldgs inc | 595 |
| silicon motion technology co | 247 |
Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC
Reductions
| Ticker | % Reduced |
|---|---|
| crinetics pharmaceuticals in | -95.93 |
| iovance biotherapeutics inc | -95.37 |
| hca healthcare inc | -95.22 |
| cytokinetics inc | -90.59 |
| roivant sciences ltd | -87.75 |
| soleno therapeutics inc | -83.2 |
| united therapeutics corp del | -76.89 |
| vnet group inc | -63.38 |
FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| vnet group inc | -86,054,700 |
| splunk inc | -22,888,200 |
| unity software inc | -12,487,500 |
| snap inc | -6,944,550 |
| blackline inc | -4,448,080 |
| mirati therapeutics inc | -118,938,000 |
| bluebird bio inc | -2,760,000 |
| blackstone inc | -222,217,000 |
FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks
Sector Distribution
FARALLON CAPITAL MANAGEMENT LLC has about 37.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 37.3 |
| Technology | 13.6 |
| Industrials | 11.6 |
| Financial Services | 10 |
| Others | 6.7 |
| Communication Services | 6.6 |
| Energy | 6.1 |
| Real Estate | 4.3 |
| Consumer Cyclical | 1.8 |
| Basic Materials | 1.7 |
Market Cap. Distribution
FARALLON CAPITAL MANAGEMENT LLC has about 71.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 49.2 |
| MEGA-CAP | 22.1 |
| MID-CAP | 18.4 |
| UNALLOCATED | 6.2 |
| SMALL-CAP | 3.7 |
Stocks belong to which Index?
About 70.6% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 62.3 |
| Others | 29.4 |
| RUSSELL 2000 | 8.3 |
FARALLON CAPITAL MANAGEMENT LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC
FARALLON CAPITAL MANAGEMENT LLC has 160 stocks in it's portfolio. About 28.8% of the portfolio is in top 10 stocks. NYT proved to be the most loss making stock for the portfolio. PXD was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.
Last Reported on: 24 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABC | cencora inc | 0.37 | 334,000 | 81,158,700 | added | 97.63 | ||
| ABNB | airbnb inc | 1.20 | 1,608,220 | 265,292,000 | new | |||
| ACHC | acadia healthcare company in | 0.00 | 2,800 | 221,816 | unchanged | 0.00 | ||
| ACLX | arcellx inc | 0.00 | 4,000 | 278,200 | unchanged | 0.00 | ||
| ADI | analog devices inc | 1.38 | 1,537,990 | 304,199,000 | added | 3.28 | ||
| AGIO | agios pharmaceuticals inc | 0.74 | 5,590,600 | 163,469,000 | added | 34.14 | ||
| AGLE | spyre therapeutics inc | 0.08 | 466,000 | 17,675,400 | new | |||
| ALNY | alnylam pharmaceuticals inc | 0.00 | 2,000 | 298,900 | unchanged | 0.00 | ||
| ALPN | alpine immune sciences inc | 0.00 | 5,900 | 233,876 | new | |||
| ALT | altimmune inc | 0.02 | 470,000 | 4,784,600 | added | 1,282 | ||
| AMLX | amylyx pharmaceuticals inc | 0.01 | 1,150,220 | 3,266,630 | new | |||
| AON | aon plc | 0.96 | 632,000 | 210,911,000 | new | |||
| APLS | apellis pharmaceuticals inc | 0.00 | 6,000 | 352,680 | unchanged | 0.00 | ||
| ARDX | ardelyx inc | 0.00 | 23,000 | 167,900 | new | |||
| ARMK | aramark | 2.63 | 17,822,900 | 579,602,000 | added | 5.47 | ||
| ARQT | arcutis biotherapeutics inc | 0.08 | 1,780,000 | 17,639,800 | new | |||
| ARYD | arya sciences acqu corp iv | 0.01 | 200,000 | 2,254,000 | unchanged | 0.00 | ||
| ASND | ascendis pharma a/s | 0.07 | 109,000 | 16,477,500 | new | |||
| AXSM | axsome therapeutics inc | 0.00 | 4,000 | 319,200 | unchanged | 0.00 | ||
| AZN | astrazeneca plc | 0.45 | 1,459,720 | 98,895,900 | reduced | -61.83 | ||